Latest filing published 04 Jan 2012 for Altimmune, Inc., €7,708.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Jordan P. Karp: trading record in brief
Jordan P. Karp discloses dealings in Altimmune, Inc. to SEC (Form 4). The record holds 4 filings, for trades running from 21 January 2009 to 30 December 2011.
No open-market sale appears; the market trades are 1 purchase worth €11k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 3 share grants.
Most recently, on 4 January 2012, the filings show a share grant worth €7,708 in Altimmune, Inc. The latest purchase dates back some time: it was published 5,474 days ago, on 14 November 2011. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jordan P. Karp
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,863 shares@ US$1.27Common Stock, $0.0001 par value per shareSEC:0001144204-12-000512:0
- 10,000 shares@ US$1.51Common Stock, $0.0001 par value per shareSEC:0001144204-11-063366:0Canonical exit: 8 Feb 2012 (T+90)
- 25,000 sharesCommon Stock, $0.0001 par value per shareSEC:0001144204-11-056399:0
- 4,792 sharesCommon Stock, $0.0001 par value per shareSEC:0001104659-09-003885:0
4 of 4 declarations
